Serafi Rehab, Jelani Musharraf, Almramhi Mona M, Mohamoud Hussein S A, Ahmed Saleem, Alkhiary Yaser M, Zhang Jianguo, Yang Huanming, Al-Aama Jumana Y
Princess Al-Jawhara Albrahim Centre of Excellence in Research of Hereditary Disorders, King Abdulaziz University, Jeddah, Saudi Arabia.
Department of Dermatology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Ann Hum Genet. 2015 Sep;79(5):350-356. doi: 10.1111/ahg.12123. Epub 2015 Jun 23.
Dystrophic epidermolysis bullosa (DEB) is an inherited skin disorder with variable severity and heterogeneous genetic involvement. Diagnostic approaches for this condition include clinical evaluations and electron microscopy of patients' skin biopsies, followed by Sanger sequencing (SS) of a large gene (118 exons) that encodes the alpha chain of type VII collagen (COL7A1) located on Chromosome 3p21.1. However, the use of SS may hinder diagnostic efficiency and lead to delays because it is costly and time-consuming. We evaluated a 5-generation consanguineous family with 3 affected individuals presenting the severe generalised DEB phenotype. Human whole-exome sequencing (WES) revealed 2 homozygous sequence variants: the previously reported variant p.Arg578* in exon 13 and a novel variant p.Arg2063Gln in exon 74 of the COL7A1 gene. Validation by SS, performed on all family members, confirmed the cosegregation of the 2 variants with the disease phenotype. To the best of our knowledge, 2 homozygous COL7A1 variants have never been simultaneously reported in DEB patients; however, the upstream protein truncation variant is more likely to be disease-causing than the novel missense variant. WES can be used as an efficient molecular diagnostic tool for evaluating autosomal recessive forms of DEB.
营养不良性大疱性表皮松解症(DEB)是一种遗传性皮肤病,严重程度各异,遗传因素复杂。该疾病的诊断方法包括临床评估和患者皮肤活检的电子显微镜检查,随后对位于3号染色体p21.1上编码VII型胶原蛋白α链(COL7A1)的一个大基因(118个外显子)进行桑格测序(SS)。然而,使用SS可能会阻碍诊断效率并导致延迟,因为它成本高且耗时。我们评估了一个五代近亲家庭,其中3名受影响个体表现出严重的全身性DEB表型。人类全外显子测序(WES)揭示了2个纯合序列变异:先前报道的位于外显子13的p.Arg578*变异和COL7A1基因外显子74中的一个新变异p.Arg2063Gln。对所有家庭成员进行的SS验证证实了这2个变异与疾病表型的共分离。据我们所知,从未在DEB患者中同时报道过2个纯合COL7A1变异;然而,上游蛋白质截短变异比新的错义变异更可能是致病原因。WES可作为评估常染色体隐性DEB形式的有效分子诊断工具。